Replimune Group (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 08, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $55,000,000
Company Info
- Founding Year
- 2015
- Company Description
- Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
- Market
- Cancer Treatment
- Location
- Woburn, MA, USA
- Coinvestors
- Atlas Venture, Bain Capital, Cormorant Asset Management, Forbion Capital Partners, Foresite Capital, Omega Funds, Redmile Group